Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›Ascend GmbH

Medicines register · Ireland

Ascend GmbH — licensed medicines

14 medicines held by Ascend GmbH on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 06 Oct 2026, 03:23 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Fosfomycin Ascend 3 g granules for oral solution PA23429/008/001

Fosfomycin trometamol

Not marketed

Lacosamide Ascend 10 mg/ml syrup PA23429/001/001

Lacosamide

Not marketed

Mirabegron Ascend 50 mg prolonged-release tablets PA23429/003/002

Mirabegron

Not marketed

Rivaroxaban Ascend 10 mg film-coated tablets PA23429/007/002

Rivaroxaban

Not marketed

Rivaroxaban Ascend 15 mg film-coated tablets PA23429/007/003

Rivaroxaban

Not marketed

Rivaroxaban Ascend 15 mg film-coated tablets Rivaroxaban Ascend 20 mg film-coated tablets PA23429/007/005

Rivaroxaban, Rivaroxaban

Not marketed

Rivaroxaban Ascend 2.5 mg film-coated tablets PA23429/007/001

Rivaroxaban

Not marketed

Rivaroxaban Ascend 20 mg film-coated tablets PA23429/007/004

Rivaroxaban

Not marketed

Sitagliptin and Metformin hydrochloride Ascend 50 mg/1000 mg film-coated tablets PA23429/002/002

Sitagliptin phosphate, Metformin Hydrochloride

Not marketed

Sitagliptin and Metformin hydrochloride Ascend 50 mg/850 mg film-coated tablets PA23429/002/001

Sitagliptin phosphate, Metformin Hydrochloride

Not marketed

Tolvaptan Ascend 7.5 mg tablets PA23429/006/001

Tolvaptan

Not marketed

Varenicline Ascend 0.5 mg film-coated tablet PA23429/004/001

Varenicline tartrate

Not marketed

Varenicline Ascend 0.5 mg film-coated tabletsVarenicline Ascend 1 mg film-coated tablets PA23429/004/003

Varenicline tartrate, Varenicline tartrate

Not marketed

Varenicline Ascend 1 mg film-coated tablets PA23429/004/002

Varenicline tartrate

Not marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 6 October 2026. https://priyalifescience.com/medicines/company/ascend-gmbh

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.